-
Signature
-
/s/ Michelle Webb, Attorney-in-fact
-
Issuer symbol
-
ACVA
-
Transactions as of
-
28 Feb 2024
-
Net transactions value
-
-$86,700
-
Form type
-
4
-
Filing time
-
29 Feb 2024, 17:00:58 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ACVA |
Class A Common Stock |
Options Exercise |
|
+5,000 |
+2.5% |
|
207,797 |
28 Feb 2024 |
Direct |
F1 |
| transaction |
ACVA |
Class A Common Stock |
Sale |
$90,000 |
-5,000 |
-2.4% |
$18.00 |
202,797 |
28 Feb 2024 |
Direct |
F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ACVA |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5,000 |
-4.9% |
$0.000000 |
98,063 |
28 Feb 2024 |
Class B Common Stock |
5,000 |
$0.6600 |
Direct |
F4 |
| transaction |
ACVA |
Class B Common Stock |
Options Exercise |
$3,300 |
+5,000 |
+4.2% |
$0.6600* |
125,302 |
28 Feb 2024 |
Class A Common Stock |
5,000 |
|
Direct |
F1, F5 |
| transaction |
ACVA |
Class B Common Stock |
Conversion of derivative security |
$0 |
-5,000 |
-4% |
$0.000000 |
120,302 |
28 Feb 2024 |
Class A Common Stock |
5,000 |
|
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: